Surrozen, Inc./DE Increase (Decrease) in Accounts Payable
Surrozen, Inc./DE (SRZN) reported Increase (Decrease) in Accounts Payable of $345.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-06
- Surrozen, Inc./DE increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $184.00K, a 253.85% increase year-over-year.
- Surrozen, Inc./DE increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $161.00K.
- Surrozen, Inc./DE increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$90.00K, a 528.57% decline year-over-year.
- Surrozen, Inc./DE increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $184.00K, a 78.64% increase year-over-year.
- Surrozen, Inc./DE increase (decrease) in accounts payable for fiscal 2025 was $142.00K.
- Surrozen, Inc./DE increase (decrease) in accounts payable for fiscal 2024 was -$228.00K.
- Surrozen, Inc./DE increase (decrease) in accounts payable for fiscal 2023 was -$133.00K.
- Surrozen, Inc./DE increase (decrease) in accounts payable for fiscal 2022 was -$2.04M, a 337.81% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $184.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $345.00K 10-Q · filed 2026-08-06 | $255.00K derived: sum of 3 quarters · filed 2026-08-06 | $439.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $161.00K 10-Q · filed 2026-05-06 | $71.00K derived: sum of 2 quarters · filed 2026-05-06 | $255.00K derived: sum of 3 quarters · filed 2026-05-06 | $307.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$90.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $94.00K derived: sum of 2 quarters · filed 2026-03-23 | $146.00K derived: sum of 3 quarters · filed 2026-08-06 | $142.00K 10-K · filed 2026-03-23 |
| 2025-09-30 | $184.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $236.00K derived: sum of 2 quarters · filed 2026-08-06 | $232.00K 10-Q · filed 2025-11-07 | $253.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $48.00K 10-Q · filed 2026-08-06 | $69.00K derived: sum of 3 quarters · filed 2026-08-06 | $172.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$4.00K 10-Q · filed 2026-05-06 | $17.00K derived: sum of 2 quarters · filed 2026-05-06 | $120.00K derived: sum of 3 quarters · filed 2026-05-06 | $162.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | $124.00K derived: sum of 2 quarters · filed 2026-03-23 | $166.00K derived: sum of 3 quarters · filed 2026-03-23 | -$228.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $145.00K derived: sum of 2 quarters · filed 2025-11-07 | -$249.00K 10-Q · filed 2025-11-07 | -$11.00K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $42.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$352.00K 10-Q · filed 2025-08-08 | -$114.00K derived: sum of 3 quarters · filed 2025-08-08 | -$13.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$394.00K 10-Q · filed 2025-05-09 | -$156.00K derived: sum of 2 quarters · filed 2025-05-09 | -$55.00K derived: sum of 3 quarters · filed 2025-05-09 | -$40.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $238.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $339.00K derived: sum of 2 quarters · filed 2025-03-31 | $354.00K derived: sum of 3 quarters · filed 2025-03-31 | -$133.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $101.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $116.00K derived: sum of 2 quarters · filed 2024-11-06 | -$371.00K 10-Q · filed 2024-11-06 | -$44.00K derived: sum of 4 quarters · filed 2024-11-06 |
| 2023-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$472.00K 10-Q · filed 2024-08-12 | -$145.00K derived: sum of 3 quarters · filed 2024-08-12 | -$232.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | -$487.00K 10-Q · filed 2024-05-08 | -$160.00K derived: sum of 2 quarters · filed 2024-05-08 | -$247.00K derived: sum of 3 quarters · filed 2024-05-08 | -$770.00K derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $327.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-10 | $240.00K derived: sum of 2 quarters · filed 2024-04-10 | -$283.00K derived: sum of 3 quarters · filed 2024-04-10 | -$2.04M 10-K · filed 2024-04-10 |
| 2022-09-30 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$610.00K derived: sum of 2 quarters · filed 2023-11-08 | -$2.37M 10-Q · filed 2023-11-08 | -$1.64M derived: sum of 4 quarters · filed 2023-11-08 |
| 2022-06-30 | -$523.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$2.28M 10-Q · filed 2023-08-09 | -$1.55M derived: sum of 3 quarters · filed 2023-08-09 | -$784.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$1.75M 10-Q · filed 2023-05-10 | -$1.03M derived: sum of 2 quarters · filed 2023-05-10 | -$261.00K derived: sum of 3 quarters · filed 2023-05-10 | -$1.33M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $728.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $1.49M derived: sum of 2 quarters · filed 2023-03-31 | $426.00K derived: sum of 3 quarters · filed 2023-03-31 | $857.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $766.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$302.00K derived: sum of 2 quarters · filed 2022-11-14 | $129.00K 10-Q · filed 2022-11-14 | $661.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$1.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$637.00K 10-Q · filed 2022-08-11 | -$105.00K derived: sum of 3 quarters · filed 2022-08-11 | |
| 2021-03-31 | $431.00K 10-Q · filed 2022-05-11 | $963.00K derived: sum of 2 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $532.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $537.00K 10-K · filed 2022-03-28 | ||
| 2020-09-30 | $5.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |